Biogen Inc (NASDAQ: BIIB)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 04/09/2021
Closing price: 268.17
Support price level: | $258.18 |
Resistance price level: | $289.24 |
Relative strength index (14-day RSI) | 51.3 |
Beta | 0.98 |
- With a -15.4 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- Down 3.8 percent, BIIB is one of this week's biggest decliners.
- BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 43.7%.
- Volatility is forecast to fall over the next month.
- Price crossed below 50-day moving average this week - a bearish signal.
Low | High | Price as % of Range |
$236.26 | $355.63 | 31.0% |
200 day | 50 day | 20 day | 10 day |
$269.13 | $271.75 | $269.88 | $273.87 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
44.1% | 44.1% | 43.7% | 44.6% |
- 11.9% in the next week.
- 25.2% in the next month.
- 108.4% in the next year.
Company news for Biogen Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks